Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 49.04 USD -2.62%
Market Cap: 4.8B USD
Have any thoughts about
Biohaven Pharmaceutical Holding Company Ltd?
Write Note

Biohaven Pharmaceutical Holding Company Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biohaven Pharmaceutical Holding Company Ltd
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Net Change in Cash
$9.5m
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
-$6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$669m
CAGR 3-Years
57%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$25.7B
CAGR 3-Years
N/A
CAGR 5-Years
-116%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$148.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash?
Net Change in Cash
9.5m USD

Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash amounts to 9.5m USD.

What is Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-49%

Over the last year, the Net Change in Cash growth was -94%. The average annual Net Change in Cash growth rates for Biohaven Pharmaceutical Holding Company Ltd have been -49% over the past three years .

Back to Top